lifestyle.thedishh.com

Author: BIOMARIN PHARMACEUTICAL INC.

BioMarin Appoints Arpit Davé Chief Digital and Information Officer

January 14, 2026
BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA

January 14, 2026
BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA

January 13, 2026
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook

January 5, 2026
FDA Accepts BioMarin’s PALYNZIQ® (pegvaliase-pqpz) Supplemental Biologics License Application for Priority Review to Expand Use to Adolescents Aged 12-17 with Phenylketonuria

October 29, 2025
BioMarin Reports Third Quarter 2025 Results and Provides Corporate Update

October 28, 2025
BioMarin to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Monday, October 27, 2025, at 4:30pm ET

October 28, 2025